ESC 365 - Safety and efficacy of oral anticoagulation discontinuation in high thromboembolic risk patients at long term follow-up after successful atrial fibrillation ablation

ESC Premium Access

Safety and efficacy of oral anticoagulation discontinuation in high thromboembolic risk patients at long term follow-up after successful atrial fibrillation ablation

Session: Poster Session 3 - Atrial fibrillation ablation - Results from large cohorts

Topic: Catheter Ablation of Arrhythmias

Speaker: Doctor S. Themistoclakis (Venice, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Sakis Themistoclakis

Hospital of the Angelo Mestre, Venice (Italy)

2 presentations

0 follower

9 more presentations in this session

Safety of atrial fibrillation catheter ablation in the elderly

Speaker: Doctor N. Karim (London, GB)

Outcomes of catheter ablation for atrial fibrillation based on sex: data from the cabana trial

Speaker: Assistant Professor K. Monahan (Rochester, US)

Diagnostic yield of holter recording after atrial fibrillation ablation - detection of asymptomatic recurrences during a one-year follow-up period

Speaker: Mr S. van Vugt (Nijmegen, NL)

Feasibility and safety of same day discharge after radiofrequency catheter ablation for paroxysmal atrial fibrillation

Speaker: Doctor A. Rajendra (Birmingham, US)

Role of pre-procedural CT-imaging on catheter ablation in patients with atrial fibrillation: procedural outcomes and radiological exposure.

Speaker: Doctor A. Di Cori (Pisa, IT)

Access the full session

Poster Session 3 - Atrial fibrillation ablation - Results from large cohorts

Speakers: Doctor S. Themistoclakis, Doctor N. Karim, Assistant Professor K. Monahan, Mr S. van Vugt, Doctor A. Rajendra...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources